Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ambiotis is a private French preclinical contract research organization focused on inflammation and the active resolution of inflammation. The company provides research services to biopharma, dermo-cosmetic, nutraceutical, clinical, and animal health customers, using cell-based assays, animal models, biomarker analysis, and mass spectrometry-based lipid mediator profiling. Rather than developing a proprietary therapeutic pipeline, Ambiotis supports external partners with proof-of-concept studies and mechanism-of-action work from early preclinical research through clinical assay support. Its core differentiation is specialized expertise in inflammation-resolution biology, an area the company describes as a worldwide first for a CRO. Ambiotis is headquartered in Toulouse, France and appears to operate as an active private company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ambiotis.